ENSYSCE BIOSCIENCES, INC. Diluted Shares Outstanding (Weighted Average)
ENSYSCE BIOSCIENCES, INC. (ENSC) reported Diluted Shares Outstanding (Weighted Average) of 13.04 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- ENSYSCE BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 13.04M shares, a 491.91% increase year-over-year.
- ENSYSCE BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 6.84M shares, a 388.13% increase year-over-year.
- ENSYSCE BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 3.72M shares, a 201.79% increase year-over-year.
- ENSYSCE BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 2.89M shares, a 337.71% increase year-over-year.
- ENSYSCE BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 2.56M shares, a 266.55% increase from fiscal 2024.
- ENSYSCE BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 697.69K shares, a 362.24% increase from fiscal 2023.
- ENSYSCE BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 150.94K shares, a 16.11% decline from fiscal 2022.
- ENSYSCE BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 179.93K shares, a 99.11% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 13.04M shares 10-Q · filed 2026-08-13 | 9.95M shares 10-Q · filed 2026-08-13 | 7.87M shares derived: average of 3 quarters · filed 2026-08-13 | 6.62M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 6.84M shares 10-Q · filed 2026-05-15 | 5.28M shares derived: average of 2 quarters · filed 2026-05-15 | 4.48M shares derived: average of 3 quarters · filed 2026-05-15 | 3.91M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 3.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 3.31M shares derived: average of 2 quarters · filed 2026-03-30 | 2.94M shares derived: average of 3 quarters · filed 2026-08-13 | 2.56M shares 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | 2.89M shares 10-Q · filed 2025-11-14 | 2.54M shares derived: average of 2 quarters · filed 2026-08-13 | 2.17M shares 10-Q · filed 2025-11-14 | 1.93M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 2.20M shares 10-Q · filed 2026-08-13 | 1.80M shares 10-Q · filed 2026-08-13 | 1.61M shares derived: average of 3 quarters · filed 2026-08-13 | 1.37M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 1.40M shares 10-Q · filed 2026-05-15 | 1.32M shares derived: average of 2 quarters · filed 2026-05-15 | 1.10M shares derived: average of 3 quarters · filed 2026-05-15 | 970.64K shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | 1.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 946.80K shares derived: average of 2 quarters · filed 2026-03-30 | 827.14K shares derived: average of 3 quarters · filed 2026-03-30 | 697.69K shares 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | 659.36K shares 10-Q · filed 2025-11-14 | 9.89M shares 10-Q · filed 2024-11-12 | 623.59K shares derived: average of 2 quarters · filed 2025-11-14 | 518.84K shares 10-Q · filed 2025-11-14 | 7.78M shares 10-Q · filed 2024-11-12 | -1.05M shares derived: average of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | 587.82K shares 10-Q · filed 2025-08-13 | 8.82M shares 10-Q · filed 2024-08-14 | 509.35K shares 10-Q · filed 2025-08-13 | 7.64M shares 10-Q · filed 2024-08-14 | -1.62M shares derived: average of 3 quarters · filed 2025-08-13 | -444.86K shares derived: average of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | 379.63K shares 10-Q · filed 2025-05-13 | 5.69M shares 10-Q · filed 2024-05-13 | -2.73M shares derived: average of 2 quarters · filed 2025-05-13 | -789.09K shares derived: average of 3 quarters · filed 2025-05-13 | -23.29K shares derived: average of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | -5.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -1.37M shares derived: average of 2 quarters · filed 2025-03-10 | -157.59K shares derived: average of 3 quarters · filed 2025-03-10 | 150.94K shares 10-K · filed 2025-03-10 | 2.26M shares 10-K · filed 2024-03-15 | |||
| 2023-09-30 | 3.09M shares 10-Q · filed 2024-11-12 | 2.68M shares derived: average of 2 quarters · filed 2024-11-12 | 2.15M shares 10-Q · filed 2024-11-12 | 1.68M shares derived: average of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | 2.27M shares 10-Q · filed 2024-08-14 | 1.67M shares 10-Q · filed 2024-08-14 | 1.21M shares derived: average of 3 quarters · filed 2024-08-14 | 948.05K shares derived: average of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | 1.05M shares 10-Q · filed 2024-05-13 | 678.68K shares derived: average of 2 quarters · filed 2024-05-13 | 506.02K shares derived: average of 3 quarters · filed 2024-05-13 | 414.92K shares derived: average of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | 303.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 231.94K shares derived: average of 2 quarters · filed 2024-03-15 | 201.83K shares derived: average of 3 quarters · filed 2024-03-15 | 179.93K shares 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | 160.72K shares 10-Q · filed 2023-11-09 | 151.17K shares derived: average of 2 quarters · filed 2023-11-09 | 138.85K shares 10-Q · filed 2023-11-09 | 13.00M shares derived: average of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | 141.62K shares 10-Q · filed 2023-08-11 | 127.73K shares 10-Q · filed 2023-08-11 | 17.27M shares derived: average of 3 quarters · filed 2023-08-11 | 19.02M shares derived: average of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | 27.29M shares 10-Q · filed 2022-05-12 | 25.84M shares derived: average of 2 quarters · filed 2022-05-12 | 25.31M shares derived: average of 3 quarters · filed 2022-05-12 | |||||
| 2021-12-31 | 24.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 24.32M shares derived: average of 2 quarters · filed 2022-03-31 | 20.16M shares 10-K · filed 2022-03-31 | |||||
| 2021-09-30 | 24.26M shares 10-Q · filed 2021-11-15 | 18.76M shares 10-Q · filed 2021-11-15 | ||||||
| 2021-03-31 | 15.83M shares 10-Q · filed 2022-05-12 | 17.28M shares derived: average of 2 quarters · filed 2022-05-12 | 17.14M shares derived: average of 3 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | 18.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 17.79M shares derived: average of 2 quarters · filed 2022-03-31 | 16.51M shares 10-K · filed 2022-03-31 | |||||
| 2020-09-30 | 16.85M shares 10-Q · filed 2021-11-15 | 15.77M shares 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |